Go here to see the original:
Tarsus Pharmaceuticals, Inc. Schedules Conference Call and Webcast to Announce Saturn-1 Phase 2b/3 Pivotal Trial Results for TP-03 for the Treatment...

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh